Little is known about contaminated surfaces as a route of transmission for SARS-CoV- 2 and a systematic review is missing and urgently needed to provide guidelines for future research studies. As such, the aim of the present study was to review the current scientific knowledge and to summarize the existing studies in which SARS-CoV-2 has been detected in inanimate surfaces. This systematic review includes studies since the emergence of SARS-CoV-2, available in PubMed/MEDLINE and Scopus. Duplicate publications were removed, and exclusion criteria was applied to eliminate unrelated studies, resulting in 37 eligible publications. The present study provides the first overview of SARS-CoV-2 detection in surfaces. The highest detection rates occurred in hospitals and healthcare facilities with COVID-19 patients. Contamination with SARS-CoV-2 on surfaces was detected in a wide range of facilities and surfaces. There is a lack of studies performing viability testing for SARS-CoV-2 recovered from surfaces, and consequently it is not yet possible to assess the potential for transmission via surfaces.

O presente documento tem por objetivo informar sobre os modos de transmissão deste processo infeccioso, a tipologia dos equipamentos de proteção individual (EPIs), suas características, bem como orientar tecnicamente o uso correto destes EPIs no ambiente hospitalar pelos fisioterapeutas, e sobre a prevenção de transmissão cruzada por estes profissionais durante a pandemia de COVID-19. Além disso, estas recomendações nacionais estimulam os fisioterapeutas a se protegerem e utilizarem os EPIs adequadamente. Sabe-se que os fisioterapeutas são imprescindíveis na linha de frente de cuidados ao paciente com COVID-19, e que muitos procedimentos terapêuticos utilizados no contexto hospitalar são fontes dispersoras de aerossóis e assim fornecedores de risco ao ambiente e ao profissional. Desta forma, a proteção destes profissionais durante sua atividade-fim e do seu respectivo local de trabalho é motivo de grande preocupação por parte da ASSOBRAFIR.

Since late 2019, the number of COVID-19 patients has gradually increased in certain regions as consecutive waves of infections hit countries. Whenever this wave hits the corresponding areas, the entire healthcare system must respond quickly to curb the diseases, morbidities, and mortalities in intensive care settings. The healthcare team involved in COVID-19 patients’ care must work tirelessly without having breaks. Our understanding of COVID-19 is limited as new challenges emerge with new COVID-19 variants appearing in different world regions. Though medical therapies are finding solutions to deal with the disease, there are few recommendations for respiratory rehabilitation therapies. A group of respiratory rehabilitation care professionals in Saudi Arabia and international experts have agreed with the World Health bodies such as the World Health Organization (WHO) on the treatment and rehabilitation of patients with COVID-19. Professionals participating in COVID-19 patient treatment, rehabilitation, and recovery formulated respiratory rehabilitation guidelines based on the DELPHI Method, combining scientific research and personal practical experience. As a result, it is envisaged that the number of individuals in the region suffering from respiratory ailments due to post-COVID-19 will decrease. This narrative review and clinical expertise guidelines may give physiotherapists acceptable and standard clinical guideline protocols for treating COVID-19 patients.

No abstract

No abstract

No abstract

No abstract

Background and Objectives Although peak oxygen uptake (VO2peak) is one of the most important measures in clinical practice, the high cost and time consumption have led to the search for simpler devices and the development of the estimating cardiopulmonary fitness (eCPF) equation. Since the lungs are one of the sites most affected by rheumatoid arthritis (RA), this study aimed to create a predictive equation for VO2peak obtained by simple sampling technology in women with RA‐associated interstitial lung disease (RA‐ILD). Methods This cross‐sectional study evaluated 47 women with RA‐ILD. The participants underwent the following evaluations: computed tomography (CT); evaluation of disease activity through the Clinical Disease Activity Index (CDAI); measurement of physical function using the Health Assessment Questionnaire disability index (HAQ‐DI); pulmonary function testing, including spirometry, diffusing capacity for carbon monoxide (DlCO), nitrogen single‐breath washout (N2SBW) test, and impulse oscillometry; and cardiopulmonary exercise testing (CPET) using FitMate™. Results VO2peak was correlated with age (r = −0.550, p < 0.0001), rheumatoid factor (r = −0.443, p = 0.002), anti‐cyclic citrullinated peptide antibodies (r = −0.410, p = 0.004), CDAI (r = −0.462, p = 0.001), HAD‐DI (r = −0.486, p = 0.0005), forced vital capacity (r = 0.491, p = 0.0004), DlCO (r = 0.621, p < 0.0001), phase III slope of N2SBW (r = −0.647, p < 0.0001), resonance frequency (Fres, r = −0.717, p < 0.0001), integrated low‐frequency reactance (r = −0.535, p = 0.0001), and the inhomogeneity of respiratory system resistance between 4 and 20 Hz (r = −0.631, p < 0.0001). In the CT examination, patients with extensive ILD had significantly lower VO2peak than patients with limited ILD (p < 0.0001). In the stepwise forward regression analysis, Fres, DlCO and age explained 61% of the VO2peak variability. Conclusions As assessed by CPET, women with RA‐ILD show reduced cardiopulmonary fitness, which can be explained at least in part by the presence of small airway disease, deterioration of pulmonary gas exchange, and advanced age. These associations of pulmonary variables with eCPF may be clinically important and support the use of the eCPF equation to improve patient outcomes.